Related Experiment Videos
Hyperlipidemia following renal transplantation
Transactions - American Society for Artificial Internal Organs
|January 1, 1976
Summary
Hyperlipidemia is common in renal transplant patients, linked to prednisone dosage and graft function. Early post-transplant lipid levels correlate with cumulative prednisone exposure.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Medicine
Background:
- Hyperlipidemia is a frequent complication in renal transplant recipients.
- Understanding lipid profiles is crucial for managing post-transplant cardiovascular risk.
Purpose of the Study:
- To investigate the prevalence and characteristics of hyperlipidemia in adult renal transplant patients.
- To identify factors associated with hyperlipidemia, including immunosuppressive therapy and graft function.
Main Methods:
- Analysis of lipid profiles (cholesterol, triglycerides) in 175 adult renal transplant patients.
- Lipoprotein electrophoresis to determine hyperlipoproteinemia types.
- Correlation analysis with prednisone dosage, obesity, graft duration, and donor type.
Main Results:
- 59% of patients exhibited hyperlipidemia (hypercholesterolemia and hypertriglyceridemia), primarily types IIa, IIb, and IV.
- Prednisone dosage correlated with both serum cholesterol and triglyceride levels.
- Hypertriglyceridemia was more common in cadaveric donor recipients, who received higher corticosteroid doses.
- In a subset of 17 patients, hyperlipidemia developed within 8 weeks post-transplant and persisted.
Conclusions:
- Hyperlipidemia is highly prevalent in renal transplant patients and is significantly influenced by prednisone dosage.
- Early post-transplant lipid abnormalities are linked to cumulative prednisone exposure.
- Donor type and graft function duration may also play roles in lipid metabolism post-transplantation.